Ireland
--:--IST
Recruiting Observational

Study of Individual Neurocognitive Changes Associated With the Training of the Working Memory.

NCT07851051 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-09-29
Last updated
2026-10-01

Condition(s) studied

Mental Health

Study summary

8 participants including 2 pilots. The 2 pilot participants will each execute an MRI acquisition session in order to adjust the experimental paradigm

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: The inclusion criteria include * age between 18 and 30 years, * right-handedness (assessed using the Edinburgh Handedness Inventory), * native French speaker, affiliation with the French national health insurance system * provision of written informed consent prior to participation. Exclusion Criteria: Exclusion criteria include: * contraindications to MRI, * neurological or psychiatric disorders * history of traumatic brain injury * any geographical or psychological condition preventing full compliance with the study protocol.

Primary outcome measure(s)

  • Working memory performance - Cogmed — 5 week.
    Cognitive trajectories will be characterized using performance measures derived from the home-based training.
  • Working memory performance - CANTAB — 2 week
    Cognitive trajectories will be characterized using performance measures derived from the Spatial Span (SSP) task from the CANTAB battery, administered under standardized conditions at GHU Paris Psychiatry and Neurosciences.
  • Multimodal MRI data — 2 week
    Multimodal MRI data - including anatomical, resting-state, working memory (WM) task-based functional, and diffusion-weighted sequences - will be acquired repeatedly over a six-week period during WM training, as well as before and after the training phase.

Trial sites (1)

FacilityCityRegionStatus
CACHIA Paris France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07851051 on ClinicalTrials.gov ↗ ← All trials in France